Get started
Author

Niels Smedegaard Andersen

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
2008 · Christian H. Geisler, Arne Kolstad, et al. · Blood · 623
PDF
Nordic MCL 2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur
2012 · Christian H. Geisler, Arne Kolstad, et al. · British Journal of Haematology · 272
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
2009 · Christiane Pott, Eva Hoster, et al. · Blood · 272
PDF
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial ( MCL 2): prolonged remissions without survival plateau
2016 · Christian W. Eskelund, Arne Kolstad, et al. · British Journal of Haematology · 217
PDF
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
2014 · Peter Dreger, Johannes Schetelig, et al. · Blood · 199
Failure of Immunologic Purging in Mantle Cell Lymphoma Assessed by Polymerase Chain Reaction Detection of Minimal Residual Disease
1997 · Niels S. Andersen, John W. Donovan, et al. · Blood · 145
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
2009 · Niels S. Andersen, Lone B. Pedersen, et al. · Journal of Clinical Oncology · 127
PDF
A Danish population-based analysis of 105 mantle cell lymphoma patients
2002 · N.S Andersen, M.K Jensen, et al. · European Journal of Cancer · 99
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant
2003 · Niels S. Andersen, Lone Pedersen, et al. · European Journal Of Haematology · 82
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
2018 · Peter Dreger, Mauricette Michallet, et al. · Bone Marrow Transplantation · 77
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation
2019 · Lia Minculescu, Hanne Vibeke Marquart, et al. · Frontiers in Immunology · 71
PDF
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
2016 · Arne Kolstad, Lone Bredo Pedersen, et al. · Transplantation and Cellular Therapy · 64
PDF
Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation
2016 · Lia Minculescu, Hanne Vibeke Marquart, et al. · Transplantation and Cellular Therapy · 64
Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures
2000 · Niels S. Andersen, Jørgen K. Larsen, et al. · Blood · 64
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation
2017 · J Schetelig, L C de Wreede, et al. · Bone Marrow Transplantation · 43
Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma
2002 · Niels S. Andersen, John W. Donovan, et al. · Experimental Hematology · 32
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party
2018 · Charalampia Kyriakou, Ariane Boumendil, et al. · Transplantation and Cellular Therapy · 31
PDF
Centre characteristics and procedure‐related factors have an impact on outcomes of allogeneic transplantation for patients with CLL : a retrospective analysis from the European Society for Blood and Marrow Transplantation ( EBMT )
2017 · Johannes Schetelig, Liesbeth C. de Wreede, et al. · British Journal of Haematology · 30
PDF
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors
2020 · Brian Kornblit, Barry E. Storer, et al. · Blood · 27
PDF
B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule
2007 · Ulrika Andréasson, Sara Ek, et al. · Cancer Letters · 25
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation
2020 · Lia Minculescu, Anne Fischer-Nielsen, et al. · Frontiers in Immunology · 24
PDF
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes
2020 · Eileen Wedge, Henrik Sengeløv, et al. · Transplantation and Cellular Therapy · 17
Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre‐ and post‐transplantation cytokine responses in stimulated whole blood
2021 · Lars Klingen Gjærde, Patrick Terrence Brooks, et al. · Scandinavian Journal of Immunology · 16
PDF
C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
2017 · Lia Minculescu, Brian Thomas Kornblit, et al. · Transplantation and Cellular Therapy · 16
PDF
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT
2017 · Michel van Gelder, Dimitris Ziagkos, et al. · Clinical Lymphoma Myeloma & Leukemia · 16
Works count: 93
Citation count: 2,888
H-index: 21
I10-index: 33
Year
Topic
Type